FdaApplication
ANDA 218984
Identifiers
- fda_app_no: ANDA218984
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPS LLC |
| application_type | ANDA |
| approval_date | 2026-03-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACAMPROSATE CALCIUM | ACAMPROSATE CALCIUM | 333MG | TABLET, DELAYED RELEASE;ORAL |
1 product